MX361470B - Métodos para la síntesis de etilfumaratos y su uso como intermediarios. - Google Patents

Métodos para la síntesis de etilfumaratos y su uso como intermediarios.

Info

Publication number
MX361470B
MX361470B MX2014013075A MX2014013075A MX361470B MX 361470 B MX361470 B MX 361470B MX 2014013075 A MX2014013075 A MX 2014013075A MX 2014013075 A MX2014013075 A MX 2014013075A MX 361470 B MX361470 B MX 361470B
Authority
MX
Mexico
Prior art keywords
synthesis
intermediates
activated
improved
disclosed embodiments
Prior art date
Application number
MX2014013075A
Other languages
English (en)
Spanish (es)
Other versions
MX2014013075A (es
Inventor
Kraft Kelly
Freeman John
Serwinski Paul
Pavia Vinnie
Phantsiel Otto
Kaur Navneet
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp filed Critical Mannkind Corp
Publication of MX2014013075A publication Critical patent/MX2014013075A/es
Publication of MX361470B publication Critical patent/MX361470B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/39Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2014013075A 2012-04-27 2013-03-15 Métodos para la síntesis de etilfumaratos y su uso como intermediarios. MX361470B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261639536P 2012-04-27 2012-04-27
PCT/US2013/032162 WO2013162764A1 (en) 2012-04-27 2013-03-15 Methods for the synthesis of ethylfumarates and their use as intermediates

Publications (2)

Publication Number Publication Date
MX2014013075A MX2014013075A (es) 2015-08-14
MX361470B true MX361470B (es) 2018-12-06

Family

ID=49477848

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014013075A MX361470B (es) 2012-04-27 2013-03-15 Métodos para la síntesis de etilfumaratos y su uso como intermediarios.

Country Status (16)

Country Link
US (6) US9193691B2 (instruction)
EP (1) EP2841422B1 (instruction)
JP (1) JP6241682B2 (instruction)
KR (1) KR20150023315A (instruction)
CN (2) CN104797563B (instruction)
AU (2) AU2013252901B2 (instruction)
BR (1) BR112014026809A2 (instruction)
CA (1) CA2871126C (instruction)
HK (1) HK1207382A1 (instruction)
IL (1) IL235247A0 (instruction)
IN (1) IN2014DN09774A (instruction)
MX (1) MX361470B (instruction)
RU (1) RU2014143116A (instruction)
SG (1) SG11201406970QA (instruction)
WO (1) WO2013162764A1 (instruction)
ZA (1) ZA201408429B (instruction)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
JP4681231B2 (ja) 2002-03-20 2011-05-11 マンカインド コーポレイション 吸入装置
DE602005024413D1 (de) 2004-08-20 2010-12-09 Mannkind Corp Katalyse der diketopiperazinsynthese
ES2543007T3 (es) 2004-08-23 2015-08-13 Mannkind Corporation Micropartículas que comprenden sales de dicetopiperazina para la administración de fármacos
ES2640282T3 (es) 2005-09-14 2017-11-02 Mannkind Corporation Método de formulación de fármacos basado en el aumento de la afinidad de superficies de micropartículas cristalinas para agentes activos
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CN106039494B (zh) 2008-06-13 2019-12-24 曼金德公司 干粉吸入器和用于药物输送的系统
CN102065942B (zh) 2008-06-20 2013-12-11 曼金德公司 用于对吸入工作进行实时描绘的交互式设备和方法
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
MX2011009512A (es) 2009-03-11 2011-11-29 Mannkind Corp Aparato, sistema y metodo para medir la resistencia de un inhalador.
MY157166A (en) 2009-06-12 2016-05-13 Mankind Corp Diketopiperazine microparticles with defined specific surface areas
US9016147B2 (en) 2009-11-03 2015-04-28 Mannkind Corporation Apparatus and method for simulating inhalation efforts
AU2011271097B2 (en) 2010-06-21 2014-11-27 Mannkind Corporation Dry powder drug delivery system and methods
SG194034A1 (en) 2011-04-01 2013-11-29 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
KR20140095483A (ko) 2011-10-24 2014-08-01 맨카인드 코포레이션 통증을 치료하기 위한 방법 및 조성물
IN2014DN09774A (instruction) * 2012-04-27 2015-07-31 Mannkind Corp
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
SG10201708090TA (en) 2013-03-15 2017-11-29 Mannkind Corp Microcrystalline diketopiperazine compositions and methods
CA2918369C (en) 2013-07-18 2021-06-29 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
WO2015021064A1 (en) 2013-08-05 2015-02-12 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN117646042B (zh) * 2023-11-13 2025-04-11 浙江工业大学 一种富马酸单酯的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3407203A (en) 1965-03-22 1968-10-22 Union Carbide Corp Novel process for the preparation of diketopiperazines
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
DE10019879A1 (de) 2000-04-20 2001-10-25 Degussa Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
DE602005024413D1 (de) 2004-08-20 2010-12-09 Mannkind Corp Katalyse der diketopiperazinsynthese
ES2543007T3 (es) * 2004-08-23 2015-08-13 Mannkind Corporation Micropartículas que comprenden sales de dicetopiperazina para la administración de fármacos
EP1986679B1 (en) * 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
CA2748490C (en) * 2008-12-29 2016-10-04 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8314106B2 (en) * 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2427430B1 (en) * 2009-05-04 2014-09-10 The Royal Institution for the Advancement of Learning/McGill University 5-oxo-ete receptor antagonist compounds
CN101851213A (zh) 2010-06-21 2010-10-06 于清 3,6-双(4-双反丁烯二酰基氨丁基)-2,5-二酮哌嗪及其盐取代物的合成方法
WO2012109256A2 (en) 2011-02-10 2012-08-16 Mannkind, Corp Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine
IN2014DN09774A (instruction) * 2012-04-27 2015-07-31 Mannkind Corp

Also Published As

Publication number Publication date
US20190010131A1 (en) 2019-01-10
JP2015519321A (ja) 2015-07-09
CN104797563B (zh) 2017-12-15
AU2018201397A1 (en) 2018-03-22
US20230057608A1 (en) 2023-02-23
US10071969B2 (en) 2018-09-11
BR112014026809A2 (pt) 2017-06-27
US20160159753A1 (en) 2016-06-09
SG11201406970QA (en) 2014-11-27
US20250109109A1 (en) 2025-04-03
MX2014013075A (es) 2015-08-14
EP2841422B1 (en) 2019-08-28
US12202807B2 (en) 2025-01-21
CA2871126A1 (en) 2013-10-31
US20130289278A1 (en) 2013-10-31
IN2014DN09774A (instruction) 2015-07-31
AU2013252901A1 (en) 2014-11-06
AU2018201397B2 (en) 2019-05-02
CN104797563A (zh) 2015-07-22
CN107879938A (zh) 2018-04-06
HK1207382A1 (en) 2016-01-29
US9193691B2 (en) 2015-11-24
IL235247A0 (en) 2014-12-31
WO2013162764A1 (en) 2013-10-31
ZA201408429B (en) 2021-05-26
US10858325B2 (en) 2020-12-08
KR20150023315A (ko) 2015-03-05
AU2013252901B2 (en) 2017-11-30
CA2871126C (en) 2020-07-14
RU2014143116A (ru) 2016-06-20
US11479535B2 (en) 2022-10-25
EP2841422A1 (en) 2015-03-04
US20210114994A1 (en) 2021-04-22
EP2841422A4 (en) 2016-04-13
JP6241682B2 (ja) 2017-12-06

Similar Documents

Publication Publication Date Title
MX361470B (es) Métodos para la síntesis de etilfumaratos y su uso como intermediarios.
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
WO2012050975A3 (en) Novel circular mammalian rna molecules and uses thereof
ATE502939T1 (de) Disubstituierte alkyl-8-azabicycloä3.2.1üoktan- verbindungen als mu-opioid-rezeptorantagonisten
PH12014501179B1 (en) New bicyclic dihydroisoquinoline-1-one derivatives
CL2009000650A1 (es) Compuestos derivados de amino-pirazina, inhibidores de cinasa-pi 3; composicion farmaceutica; y uso para el tratamiento de condiciones inflamatorias o alérgicas, tales como enfermedades respiratorias, artritis reumatoide, colitis ulcerativa, entre otras
TNSN08513A1 (en) Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands
MY168935A (en) Synthesis of heterocyclic compounds
UA94639C2 (ru) Трициклические соединения и их применение как модуляторов глюкокортикоидного рецептора
EP2526199A4 (en) PROCESS FOR PRODUCING ZINC FINGERUCLEASES WITH CHANGED EFFECT
EP2686354A4 (en) SYNTHESIS 2,3,3,3-TETRAFLUORPROPHIC FLUOROPOLYMERS
MX350211B (es) Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico.
HUE037914T2 (hu) Reaktor és eljárás foszgén elõállításához
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
MX2012007341A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
EA201391618A1 (ru) Комбинация, содержащая умеклидиний и кортикостероид
CL2011001427A1 (es) Compuestos derivados de 4-azetidinil-1-heteroaril-ciclohexanol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, aterosclerosis, artritis reumatoide, entre otras.
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
WO2011129636A3 (ko) 초급속연소법을 이용한 나노전극재료 합성방법 및 그 방법으로 합성된 나노전극재료
MX346507B (es) Proceso para producir 2,3,3,3,-tetrafluoropropeno.
GB201103256D0 (en) Solid support and method of recovering biological material therefrom
MX2009008286A (es) Compuestos triciclicos y su uso como moduladores del receptor de glucocorticosteroides.
EP2613800A4 (en) MATURING THE STOMACH DARM TRAKTS
PH12012501153A1 (en) Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds

Legal Events

Date Code Title Description
FG Grant or registration